468 related articles for article (PubMed ID: 13679527)
1. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.
Crowther MA; Ginsberg JS; Julian J; Denburg J; Hirsh J; Douketis J; Laskin C; Fortin P; Anderson D; Kearon C; Clarke A; Geerts W; Forgie M; Green D; Costantini L; Yacura W; Wilson S; Gent M; Kovacs MJ
N Engl J Med; 2003 Sep; 349(12):1133-8. PubMed ID: 13679527
[TBL] [Abstract][Full Text] [Related]
2. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
Ridker PM; Goldhaber SZ; Danielson E; Rosenberg Y; Eby CS; Deitcher SR; Cushman M; Moll S; Kessler CM; Elliott CG; Paulson R; Wong T; Bauer KA; Schwartz BA; Miletich JP; Bounameaux H; Glynn RJ;
N Engl J Med; 2003 Apr; 348(15):1425-34. PubMed ID: 12601075
[TBL] [Abstract][Full Text] [Related]
3. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.
Kearon C; Gent M; Hirsh J; Weitz J; Kovacs MJ; Anderson DR; Turpie AG; Green D; Ginsberg JS; Wells P; MacKinnon B; Julian JA
N Engl J Med; 1999 Mar; 340(12):901-7. PubMed ID: 10089183
[TBL] [Abstract][Full Text] [Related]
4. The management of thrombosis in the antiphospholipid-antibody syndrome.
Khamashta MA; Cuadrado MJ; Mujic F; Taub NA; Hunt BJ; Hughes GR
N Engl J Med; 1995 Apr; 332(15):993-7. PubMed ID: 7885428
[TBL] [Abstract][Full Text] [Related]
5. Venous thrombosis in the antiphospholipid syndrome.
Farmer-Boatwright MK; Roubey RA
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
[TBL] [Abstract][Full Text] [Related]
6. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
Mohr JP; Thompson JL; Lazar RM; Levin B; Sacco RL; Furie KL; Kistler JP; Albers GW; Pettigrew LC; Adams HP; Jackson CM; Pullicino P;
N Engl J Med; 2001 Nov; 345(20):1444-51. PubMed ID: 11794192
[TBL] [Abstract][Full Text] [Related]
7. How much warfarin is enough in APS related thrombosis?
Erkan D; Lockshin MD
Thromb Res; 2004; 114(5-6):435-42. PubMed ID: 15507275
[TBL] [Abstract][Full Text] [Related]
8. [The study of Chinese optimal anticoagulant range of warfarin for venous thromboembolism].
Yang P; Wu QH; Luo XY; Kou L; Chen Z; Zhang YY; Zhou H
Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(25):1762-5. PubMed ID: 19862981
[TBL] [Abstract][Full Text] [Related]
9. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.
Chimowitz MI; Lynn MJ; Howlett-Smith H; Stern BJ; Hertzberg VS; Frankel MR; Levine SR; Chaturvedi S; Kasner SE; Benesch CG; Sila CA; Jovin TG; Romano JG;
N Engl J Med; 2005 Mar; 352(13):1305-16. PubMed ID: 15800226
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibodies in critical illness.
Dentali F; Crowther M
Crit Care Med; 2010 Feb; 38(2 Suppl):S51-6. PubMed ID: 20083914
[TBL] [Abstract][Full Text] [Related]
11. Evidence based treatment of the antiphospholipid syndrome II. Optimal anticoagulant therapy for thrombosis.
Crowther MA; Wisloff F
Thromb Res; 2005; 115(1-2):3-8. PubMed ID: 15567446
[TBL] [Abstract][Full Text] [Related]
12. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
[TBL] [Abstract][Full Text] [Related]
13. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).
Finazzi G; Marchioli R; Brancaccio V; Schinco P; Wisloff F; Musial J; Baudo F; Berrettini M; Testa S; D'Angelo A; Tognoni G; Barbui T
J Thromb Haemost; 2005 May; 3(5):848-53. PubMed ID: 15869575
[TBL] [Abstract][Full Text] [Related]
14. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
Agnelli G; Prandoni P; Santamaria MG; Bagatella P; Iorio A; Bazzan M; Moia M; Guazzaloca G; Bertoldi A; Tomasi C; Scannapieco G; Ageno W;
N Engl J Med; 2001 Jul; 345(3):165-9. PubMed ID: 11463010
[TBL] [Abstract][Full Text] [Related]
15. The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism.
Wells PS; Forgie MA; Simms M; Greene A; Touchie D; Lewis G; Anderson J; Rodger MA
Arch Intern Med; 2003 Apr; 163(8):917-20. PubMed ID: 12719200
[TBL] [Abstract][Full Text] [Related]
16. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
Huisman MV; van der Meer FJ; van Rooden CJ; Prins MH
N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14645647
[No Abstract] [Full Text] [Related]
17. Recurrent venous thrombosis despite 'optimal anticoagulation therapy' for antiphospholipid syndrome--could new oral anticoagulants solve the problem?
Balaban M; Stanrić V; Rincić G; Ledinsky M; Grbac L; Stancić N; Tomasić H
Acta Clin Croat; 2010 Dec; 49(4):469-77. PubMed ID: 21830460
[TBL] [Abstract][Full Text] [Related]
18. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
Malik V; Kupfer Y; Tessler S
N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658127
[No Abstract] [Full Text] [Related]
19. [Use of warfarin and low range INR in the prevention of recurrent venous thrombosis].
Quintero J; Torres E; Diez-Ewald M; Arteaga-Vizcaíno M; Vizcaíno G; León M; Rodríguez Z; Fernández N
Invest Clin; 2011 Sep; 52(3):230-8. PubMed ID: 21950194
[TBL] [Abstract][Full Text] [Related]
20. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.
Kearon C; Ginsberg JS; Kovacs MJ; Anderson DR; Wells P; Julian JA; MacKinnon B; Weitz JI; Crowther MA; Dolan S; Turpie AG; Geerts W; Solymoss S; van Nguyen P; Demers C; Kahn SR; Kassis J; Rodger M; Hambleton J; Gent M;
N Engl J Med; 2003 Aug; 349(7):631-9. PubMed ID: 12917299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
